TerminatedPhase 2NCT01393769

Intra-arterial Chemotherapy With Melphalan for the Treatment of Retinoblastoma (RTB) in Advanced Intraocular Stage

Studying Hereditary retinoblastoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hospital Sant Joan de Deu
Principal Investigator
Andreu Parareda, MD
Hospital Sant Joan de Deu
Intervention
Melphalan(drug)
Enrollment
5 enrolled
Eligibility
6 years · All sexes
Timeline
2009 – 2013

Study locations (1)

Collaborators

Fundació Sant Joan de Déu · Hospital Universitari General de Catalunya · Ministry of Health, Spain

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01393769 on ClinicalTrials.gov

Other trials for Hereditary retinoblastoma

Additional recruiting or active studies for the same condition.

See all trials for Hereditary retinoblastoma →

← Back to all trials